Read + Share
Amedeo Smart
Independent Medical Education
Bekaii-Saab T, Khan N, Ostojic H, Jiao X, et al. Real-world dosing of regorafenib and outcomes among patients with metastatic colorectal cancer: a retrospective analysis using US claims data. BMC Cancer 2024;24:939.PMID: 39095766
Email
LinkedIn
Privacy Policy